Recently, Jia et al., [11], found that SYY could attenuate hepatic cancer cell's invasive and metastatic capabilities by down-regulating cytokines secreted by aHSCs such as HGF, IL-6, TGF-β and VEGF in vitro. This evidence concerns the gene VEGFA and liver cancer.